Skip to main content

Publication, Part of

National Diabetes Audit, Report 1- Care Processes and Treatment Targets 2020-21, Underlying data

Audit, Survey, Other reports and statistics, Official statistics

Summary

The National Diabetes Audit (NDA) is part of the National Clinical Audit and Patient Outcomes Programme (NCAPOP) which is commissioned by the Healthcare Quality Improvement Partnership (HQIP) and funded by NHS England. The NDA is managed by NHS Digital in partnership with Diabetes UK. The National Diabetes Audit (NDA) provides a comprehensive view of diabetes care in England and Wales. It measures the effectiveness of diabetes healthcare against NICE Clinical Guidelines and NICE Quality Standards. The NDA supports improvement in the quality of diabetes care by enabling participating NHS services and organisations to: Assess local practice against NICE guidelines. Compare their care, and care outcomes, with similar services and organisations. Identify gaps or shortfalls that are priorities for improvement. Identify and share best practice and provide a comprehensive national picture of diabetes care and outcomes in England and Wales.

This data release includes the care process and treatment target measurements for 2020-21 (1st January 2020 – 31st March 2021). Data were collected during May and June 2021. The national report, scheduled for 2022, will contain commentary on the audit findings and recommendations. We will communicate to users when the publication date for this report has been finalised.



Last edited: 8 December 2021 11:33 am